"Moxalactam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
| Descriptor ID |
D009070
|
| MeSH Number(s) |
D02.065.589.099.625 D02.886.520.575 D03.633.100.300.625
|
| Concept/Terms |
6059-S- 6059-S
- 6059 S
- 6059S
- S-6059
- S 6059
- S6059
Moxalactam Disodium- Moxalactam Disodium
- Disodium, Moxalactam
- Disodium Latamoxef
- Latamoxef, Disodium
- Disodium Moxalactam
- Moxalactam, Disodium
|
Below are MeSH descriptors whose meaning is more general than "Moxalactam".
Below are MeSH descriptors whose meaning is more specific than "Moxalactam".
This graph shows the total number of publications written about "Moxalactam" by people in this website by year, and whether "Moxalactam" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Moxalactam" by people in Profiles.
-
Flynn PM, Shenep JL, Stokes DC, Hildner WK, Mackert PW, Snellgrove RL, Rehg JE. Effect of methylprednisolone on bacterial clearance and endotoxin liberation during experimental sepsis induced by gram-negative bacteria. Infect Immun. 1986 Apr; 52(1):26-30.
-
Panwalker AP, Rosenfeld J. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam. J Infect Dis. 1983 Jan; 147(1):171-2.
-
Finley RS, Fortner CL, deJongh CA, Wade JC, Newman KA, Caplan E, Britten J, Wiernik PH, Schimpff SC. Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients. Antimicrob Agents Chemother. 1982 Aug; 22(2):193-7.
-
De Jongh CA, Wade JC, Schimpff SC, Newman KA, Finley RS, Salvatore PC, Moody MR, Standiford HC, Fortner CL, Wiernik PH. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. Am J Med. 1982 Jul; 73(1):89-96.
-
Trager GM, Panwalker AP, Malow JB, Porembski PE, Ramirez CA, Zar FA. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency. Chemotherapy. 1981; 27(4):287-95.
-
Trager GM, White GW, Zimelis VM, Bryk DA, Panwalker AP. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone. Chemotherapy. 1981; 27(1):34-8.